Tivicay 50 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV326
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,756
Award facts
- Contract value 100% obligated
- $18,756.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,756.17 to AmerSourceBergen Drug Corp for the supply of Tivicay (bictegravir) 50 mg tablets in a 30-count quantity on January 7, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's facility in Conshohocken, Pennsylvania and is scheduled for completion by January 8, 2026. The award is issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2031 that enables the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Tivicay is an antiretroviral medication used in the treatment of HIV infection. As a critical supplier to the Defense Logistics Agency's Medical Supply Chain, AmerSourceBergen Drug Corp maintains established capabilities to deliver prescription medications across multiple therapeutic domains to support military treatment facilities and federal healthcare systems. The firm fixed-price delivery order structure provides the government with cost certainty while leveraging the broader IDC vehicle that streamlines procurement for essential pharmaceutical commodities required by the Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FV326?
SPE2DR26FV326 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FV326 worth?
The government has obligated $18,756 on SPE2DR26FV326.
Is contract SPE2DR26FV326 an order under another contract?
Yes. SPE2DR26FV326 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV326 competed?
The extent of competition for SPE2DR26FV326 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award